Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer

Abstract

Our results suggest that CXCL1 modulates the invasive abilities of bladder cancer cells and this chemokine may be a potential candidate of urinary biomarker for invasive bladder cancer and a possible therapeutic target for preventing tumor invasion.

References

Page 1

	Year	Citations
Cancer Statistics, 2006 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward, CA A Cancer Journal for Clinicians Epidemiology Of CancerCancer RegistrationMortality RatesUnited StatesCancer Risk Factors	2006	5.3K
An Automated Multidimensional Protein Identification Technology for Shotgun Proteomics Dirk Wolters, Michael P. Washburn, John R. Yates Analytical Chemistry Protein AnalysisMolecular BiologyBiological Mass SpectrometryPeptide ScienceAnalytical Ultracentrifugation	2001	1.8K
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis Robert M. Strieter, Peter J. Polverini, Steven L. Kunkel, Journal of Biological Chemistry	1995	1.2K
Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains Thierry Rabilloud PROTEOMICS Protein AnalysisMolecular BiologyProtein PurificationProteomic TechnologyPeptide Separations	2002	687
The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity Christina Addison, Thomas O. Daniel, Marie D. Burdick, The Journal of Immunology	2000	570
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer Sung-Woo Lee, Eijiro Nakamura, Haifeng Yang, Cancer Cell Neuro-oncologyDevelopmental BiologyGliomaDevelopmental CullingApoptosis	2005	530
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum John Welsh, Lisa M. Sapinoso, S Kern, Proceedings of the National Academy of Sciences	2003	499
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. Andrew D. Luster, Steven M. Greenberg, Philip Leder The Journal of Experimental Medicine ImmunologyImmune RegulationPathologyImmunologic MechanismInnate Immunity	1995	454
Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. C A Hébert, R.V. Vitangcol, Joffre Baker Journal of Biological Chemistry ImmunologyImmunologic MechanismInnate ImmunityImmune SystemCellular Physiology	1991	370
Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Ian Clark‐Lewis, Béatrice Dewald, Thomas Geiser, Proceedings of the National Academy of Sciences InflammationCytokineActivates NeutrophilsAllergyAutoimmune Disease	1993	259

Page 1